- Investing Ideas
- /
- Australian Pharmaceuticals & Biotech Buy the Dip
Australian Pharmaceuticals & Biotech Buy the Dip
UPDATED Aug 16, 2022
Companies which may present a buying opportunity after a dip in share price.
6 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| CUVClinuvel Pharmaceuticals | AU$20.05 | -0.05% | -28.0% | AU$990.7m | AU$26.31 | PE41.1x | E30.6% | 0.1% | ||
| IMMImmutep | AU$0.33 | -3.0% | -28.6% | AU$281.5m | AU$1.22 | PS75.6x | E62.9% | n/a | ||
| TRJTrajan Group Holdings | AU$2.21 | 5.7% | -28.9% | AU$336.0m | AU$3.22 | PS4.1x | E80.9% | n/a | ||
| KZAKazia Therapeutics | AU$0.25 | 0% | -80.2% | AU$37.4m | n/a | PS2.5x | E51.5% | n/a | ||
| AVHAVITA Medical | AU$1.98 | -10.2% | -58.0% | AU$246.9m | AU$3.34 | PS7x | E25.9% | n/a | ||
| CAUCronos Australia | AU$0.31 | 17.0% | 158.3% | AU$171.3m | n/a | PS7.9x | n/a | n/a |
Page 1 of 1